Alkaline phosphatase, especially bone isoforms affecting total serum levels, consistently associates with outcomes in CKD, suggesting a potential link between low PTH, bone fragility, and cardiovascular outcomes [90]. The gene discussed is PTH; the disease is chronic kidney disease.